secwatch.observer — SEC 8-K summary
======================================

Issuer:     Regenerative Medical Technology Group Inc. (RMTG)
CIK:        0001760026
Form:       8-K
Filed at:   2025-05-21T23:59:59+00:00
Accession:  0001213900-25-046203
Event type: earnings
Sentiment:  positive
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

RMTG Q1 sales up 67% to $1.35M; achieves operating profit of $134K
------------------------------------------------------------------

- Q1 2025 revenue $1.35M, a 67% increase over Q1 2024.
- Operating profit of $134,000 for the quarter; positive cash flow noted.
- New Turnkey membership revenue stream: clinics pay upfront fee and exclusive purchasing.
- RMTG plans one new member per quarter initially, accelerating next year.
- CEO expects continued revenue growth and sustained operating income; formal guidance forthcoming.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1760026/000121390025046203/0001213900-25-046203-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1760026/000121390025046203/ea0242973-8k_regenerative.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-046203

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer